Sha-Barbara McDaniel, MD
Gynecology · New York, NYNPI 1962581462
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Lupin Inc. at 36.2% of the total. Reporting peaked in 2019 at $795 and has fallen 97.2% since, to $22 in 2024.
Across 133 payments — averaging $14.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lupin Inc.$698
- Exeltis, USA Inc.$617
- Evofem Biosciences, Inc.$180
- Agile Therapeutics, Inc.$82
- Avion Pharmaceuticals$67
- Zyla Life Sciences, Inc.$67
- plus $220 from 7 others
What the payments were for
- Food & beverage$1,931100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lupin Inc. | 59 | $698 |
| Exeltis, USA Inc. | 37 | $617 |
| Evofem Biosciences, Inc. | 14 | $180 |
| Agile Therapeutics, Inc. | 4 | $82 |
| Avion Pharmaceuticals | 4 | $67 |
| Zyla Life Sciences, Inc. | 4 | $67 |
| AbbVie | 3 | $51 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Novum Pharma, LLC | 2 | $38 |
| Mayne Pharma Commercial LLC | 1 | $24 |
| Coopersurgical, Inc. | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Therapeuticsmd, Inc. | 1 | $17 |
How this compares
$1,931 in reported general payments places this provider in the 75th percentile of 240 gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 11 | $4,688 |
| ValacyclovirValacyclovir Hcl | 14 | $276 |
Paid to pharmacies, not to this prescriber.
Other gynecology in New York
- Arnold AdvinculaNew York$2.1M
- Tamara KolevNew York$91K
- Charles Ascher-WalshNew York$43K
- Paula CastanoNew York$31K
- Christopher EswarNew York$25K
- Neena AgarwalaNew York$17K
- Tara AllmenNew York$8K
- Jorge VenegasNew York$7K
- Molly McBrideNew York$7K
- Connie LiuNew York$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.